Actively Recruiting
Impulsivity With Borderline Personality Disorder/tMS
Led by Hôpital le Vinatier · Updated on 2024-03-07
40
Participants Needed
1
Research Sites
193 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a prospective, randomized, double-blind, parallel-group controlled trial. The aim of this research project is to compare the clinical benefits achieved in patients with Borderline Personality Disorder (BPD) following two types of intervention: ccPAS active or ccPAS sham.
CONDITIONS
Official Title
Impulsivity With Borderline Personality Disorder/tMS
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of Borderline Personality Disorder confirmed by a psychiatrist and structured interview using MINI based on DSM V criteria
You will not qualify if you...
- Contraindications to TMS or MRI such as pacemakers or other devices that interfere with magnetic fields
- Pregnant or breastfeeding women
- Use of benzodiazepines, neuroleptics, or anticonvulsants acting on GABAergic transmission within 24 hours before the protocol
- Diagnosis of other chronic psychiatric disorders including bipolar disorder type I or II and addictions except tobacco
- Under protective measures such as curatorship or guardianship
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Centre Hospitalier Le Vinatier
Bron, AURA, France, 69678 CEDEX
Actively Recruiting
Research Team
P
POULET Emmanuel, PUPH
CONTACT
S
sartelet lydie
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here